Apply Now 
Overview
The ‘Translational Advances in Stem Cells for Diabetes Symposium’ aims to promote research interaction and collaboration at the intersection of diabetes and stem cell biology. Its scope covers stem cell-derived pancreatic islets for cell therapy, the understanding of diabetes pathogenesis using stem cells, the establishment of clinically relevant iPSCs, and precision medicine in diabetes.
Chair’s Welcome Message
I extend my warm welcome to all of you to the ‘Translational Advances in Stem Cells for Diabetes Symposium’, which is organized by the Steering Committee of Qatar Biomedical Research Institute (QBRI)-Harvard Stem Cell Institute (HSCI) Agreement. This year’s symposium will bring together leaders and trainees from cutting-edge fields of stem cells and diabetes.
The event aims to enable participants to exchange new ideas and develop innovative approaches on potential treatments of diabetes using stem cells.
I look forward to welcoming you!
Dr. Essam M. Abdelalim
Chair, Steering Committee of QBRI-HSCI Agreement
Scientist at Qatar Biomedical Research Institute, Hamad Bin Khalifa University (HBKU)
Joint Assistant Professor, College of Health and Life Sciences (CHLS), HBKU
Acting Executive Director’s Welcome Message
On behalf of QBRI at HBKU, I am delighted to welcome you to the “Translational Advances in Stem Cells for Diabetes” symposium.
As part of Qatar’s National Vision 2030, we have been diligently working in alignment with the National Strategy to Prevent Diabetes in Qatar. Through our collaboration with (HSCI), we have been able to enhance QBRI’s capacity-building in stem cell technologies and perform stem cell research that increase our understanding of diabetes progression; paving the way to developing more effective treatments.
We are grateful to the QBRI-HSCI steering committee and symposium participants, as your engagement provides essential practical knowledge and strengthens the network and connections with stem cell experts.
We look forward to having you!
Dr. Omar Albagha
Acting Executive Director, Qatar Biomedical Research Institute, HBKU
Sponsors |
|
 |
 |
Organizers
This Symposium is organized by the Steering Committee of QBRI-HSCI Agreement:
Submission
Abstract Submission
The Steering Committee of QBRI-HSCI Agreement invites abstract submissions for a poster presentation in the research areas related to stem cells and/or diabetes.
Submission Guidelines
-
The submission should contain a title, author(s), institutional or business affiliation of each author. The abstract should contain a full description of the topic, providing a background, objective, methods, results and conclusion. Figures and tables should not be included in the abstract.
-
The word count of the abstract should not exceed 500 words.
-
All abstracts must be submitted electronically through the paper submission system in PDF format only.
-
Abstracts will be selected based on their originality, timeliness, significance, relevance, and clarity of presentation.
Extended deadline for abstract submission: February 15, 2023.
Extended notification of acceptance: February 18, 2023.
Upon acceptance of an abstract, a minimum of one author must attend the symposium and deliver the presentation according to the scheduled date and time.